High Cost Sharing and Specialty Drug Initiation Under Medicare Part D: A Case Study in Patients With Newly Diagnosed Chronic Myeloid Leukemia
A Medicare claims analysis of patients newly diagnosed with chronic myeloid leukemia revealed that high cost sharing was associated with reduced and/or delayed tyrosine kinase inhibitor initiation under Part D.
Insights on Health Disparities, Treatment, and Research in Psoriasis in the Latine Community
Nurse-Led Care Improves Disease Activity in Rheumatoid Arthritis
Impact of Sexual Counseling on Women With Breast Cancer
Global Trends in Ovarian Cancer Incidence Highlight Regional, Histological Variations